{"schema_version":"secwatch.filing_event.v1","accession":"0001062822-25-000019","form_type":"8-K","ticker":"LXRX","cik":"0001062822","company_name":"LEXICON PHARMACEUTICALS, INC.","filed_at":"2025-03-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.842863+00:00","generated_at":"2026-05-24T02:52:59.573044+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Lexicon licenses LX9851 to Novo Nordisk for $45M upfront; amends Oxford loan with $45M prepayment","bullets":["Exclusive worldwide license to Novo Nordisk for LX9851 (obesity/cardiometabolic); Lexicon receives $45M upfront, eligible for up to $485M regulatory/commercial milestones and $475M sales milestones.","Lexicon entitled to tiered single- to low-double-digit royalties on annual net sales; Novo Nordisk responsible for development and commercialization.","Lexicon amended its Oxford loan, using $45M upfront to prepay $42.06M principal plus $2.94M final payment; prepayment fee waived.","Loan amendment modifies amortization date to May 1, 2027 (or Dec 1, 2026 if certain event fails) and replaces net sales covenant with minimum cash covenant of $29M or 50% of outstanding principal."],"urls":{"canonical":"https://secwatch.observer/filing/0001062822-25-000019","json":"https://secwatch.observer/filing/0001062822-25-000019.json","markdown":"https://secwatch.observer/filing/0001062822-25-000019.md","text":"https://secwatch.observer/filing/0001062822-25-000019.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1062822/000106282225000019/0001062822-25-000019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1062822/000106282225000019/lxrx-20250327.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T02:52:59.573044+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}